In the latest close session, Hamilton Insurance (HG) was up +2.07% at $21.17. The stock's performance was ahead of the S&P 500's daily gain of 0.32%. Meanwhile, the Dow experienced a rise of 0.53%, and the technology-dominated Nasdaq saw an increase of 0.26%. Coming into today, shares of the provider of insurance and reinsurance services had lost 0.53% in the past month. In that same time, the Finance sector gained 3.04%, while the S&P 500 gained 4.51%. Analysts and investors alike will be keeping a close e ...

Company Overview - Horace Mann (HMN) is headquartered in Springfield and has experienced a price change of 3.44% this year [3] - The company currently pays a dividend of $0.35 per share, resulting in a dividend yield of 3.45%, which is significantly higher than the Insurance - Multi line industry's yield of 1.8% and the S&P 500's yield of 1.52% [3] Dividend Performance - The current annualized dividend of Horace Mann is $1.40, reflecting a 2.9% increase from the previous year [4] - Over the past 5 years, the company has increased its dividend 5 times, achieving an average annual increase of 3.20% [4] - The current payout ratio is 38%, indicating that the company paid out 38% of its trailing 12-month earnings per share as dividends [4] Earnings Growth Expectations - For the fiscal year 2025, the Zacks Consensus Estimate predicts earnings of $3.99 per share, representing a 25.47% increase from the previous year [5] - The company is positioned as a strong dividend play, appealing to income investors due to its solid earnings growth expectations [6] Investment Considerations - Established firms with secure profits are typically viewed as the best dividend options, while high-growth businesses often do not offer dividends [6] - Horace Mann is considered a compelling investment opportunity, not only for its strong dividend yield but also due to its current Zacks Rank of 3 (Hold) [6]

Company Overview - MGIC Investment (MTG) is a mortgage insurance company headquartered in Milwaukee, operating in the Finance sector [3] - The stock has experienced a price change of 9.11% since the beginning of the year [3] Dividend Information - MGIC Investment currently pays a dividend of $0.13 per share, resulting in a dividend yield of 2.01%, which is higher than the Insurance - Multi line industry's yield of 1.8% and the S&P 500's yield of 1.52% [3] - The company's annualized dividend of $0.52 has increased by 6.1% from the previous year [4] - Over the past 5 years, MGIC Investment has raised its dividend 4 times, achieving an average annual increase of 20.17% [4] - The current payout ratio is 17%, indicating that the company pays out 17% of its trailing 12-month earnings per share as dividends [4] Earnings Growth - The Zacks Consensus Estimate for MGIC Investment's earnings in 2025 is $2.92 per share, with an expected increase of 0.34% from the previous year [5] - Earnings growth appears solid for the current fiscal year [5] Investment Considerations - MGIC Investment is viewed as a compelling investment opportunity due to its attractive dividend and strong Zacks Rank of 2 (Buy) [6] - The company is positioned well compared to high-growth firms or tech start-ups, which typically do not provide dividends [6]

Group 1 - Oscar Health, Inc. (OSCR) stock closed at $15.53, down 3.42% from the previous day, underperforming the S&P 500's gain of 0.28% [1] - The stock has increased by 13.64% over the past month, outperforming the Finance sector's gain of 2.79% and the S&P 500's gain of 4.37% [1] Group 2 - Oscar Health, Inc. is expected to report an EPS of $0.34, reflecting a 70% increase from the same quarter last year, with revenue forecasted at $2.86 billion, indicating a 28.96% growth [2] - For the fiscal year, earnings are projected at $0.61 per share and revenue at $11.21 billion, representing increases of 510% and 22.12% respectively from the prior year [3] Group 3 - Recent analyst estimate revisions for Oscar Health, Inc. indicate positive sentiment regarding the company's business operations and profit generation capabilities [4] - The Zacks Rank system, which evaluates estimate changes, currently ranks Oscar Health, Inc. at 3 (Hold), with the consensus EPS projection remaining unchanged over the past 30 days [6] Group 4 - Oscar Health, Inc. has a Forward P/E ratio of 26.22, significantly higher than the industry average of 10.14, suggesting the company is trading at a premium [7] - The Insurance - Multi line industry, part of the Finance sector, holds a Zacks Industry Rank of 65, placing it in the top 27% of over 250 industries [7]

Key Takeaways Assurant partners with Plug to enhance certified pre-owned device offerings and customer experience. The deal boosts Plug's value with Assurant-backed warranties, faster shipping, and better device protection. Assurant gains new revenue streams and improved efficiency through Plug's expanding D2C platform.Assurant, Inc. (AIZ) , a leading global provider of protection solutions for connected devices, vehicles, and homes, has entered a strategic collaboration with Plug, a St. Louis-based direc ...

Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.While cash flow can come from bond interest or interest from other types of investments, income investors hone in on dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors of ...

Company Performance - Lemonade (LMND) has achieved a year-to-date performance of approximately 13.7%, outperforming the average gain of 8.2% in the Finance sector [4] - The Zacks Consensus Estimate for LMND's full-year earnings has increased by 1% over the past 90 days, indicating improving analyst sentiment [3] - Lemonade is categorized under the Insurance - Multi line industry, which consists of 43 stocks and has an average year-to-date gain of about 5%, further highlighting LMND's superior performance [5] Industry Comparison - The Finance group, which includes 870 companies, is currently ranked 8 within the Zacks Sector Rank, which evaluates 16 different sector groups [2] - Acadian Asset Management (AAMI), another stock in the Finance sector, has returned 43.5% year-to-date, showcasing strong performance alongside Lemonade [4] - The Financial - Miscellaneous Services industry, which includes Acadian Asset Management, has only gained 3.1% since the beginning of the year, indicating that LMND is performing better than this industry as well [6]

Core Viewpoint - Oscar Health, Inc. is expected to show significant growth in its upcoming financial results, with strong projections for earnings and revenue compared to the previous year [2][3]. Financial Performance - The stock closed at $16.55, down 1.55% from the previous trading session, underperforming the S&P 500's daily loss of 0.07% [1] - Over the past month, the stock has increased by 13.89%, outperforming the Finance sector's gain of 2.38% and the S&P 500's gain of 3.94% [1]. Earnings Estimates - The upcoming EPS is predicted to be $0.34, reflecting a 70% growth year-over-year [2]. - For the full year, analysts expect earnings of $0.61 per share, marking a 510% increase from last year [3]. Revenue Projections - The Zacks Consensus Estimate for revenue in the upcoming quarter is $2.86 billion, which is a 28.96% increase from the same period last year [2]. - For the full year, revenue is projected to be $11.21 billion, indicating a 22.12% increase from the previous year [3]. Analyst Sentiment - Recent changes in analyst estimates suggest a positive outlook for the company's business and profitability [4]. - The Zacks Rank system indicates a current rank of 3 (Hold) for Oscar Health, with a recent downward shift of 11.11% in the EPS estimate [6]. Valuation Metrics - Oscar Health is currently trading at a Forward P/E ratio of 27.41, which is significantly higher than the industry average of 9.99 [7]. - The Insurance - Multi line industry, part of the Finance sector, has a Zacks Industry Rank of 145, placing it in the bottom 42% of over 250 industries [7].

Company Overview - American International Group (AIG) is headquartered in New York and has experienced a price change of 17.95% this year [3] - The company currently pays a dividend of $0.45 per share, resulting in a dividend yield of 2.1%, which is higher than the Insurance - Multi line industry's yield of 1.82% and the S&P 500's yield of 1.54% [3] Dividend Analysis - AIG's current annualized dividend of $1.80 represents a 15.4% increase from the previous year [4] - Over the last 5 years, AIG has increased its dividend 2 times year-over-year, with an average annual increase of 5.58% [4] - The company's current payout ratio is 33%, indicating that it paid out 33% of its trailing 12-month earnings per share as dividends [4] Earnings Growth - The Zacks Consensus Estimate for AIG's earnings in 2025 is $6.24 per share, reflecting an expected increase of 26.06% from the previous year [5] Investment Considerations - AIG is considered a compelling investment opportunity due to its strong dividend profile and current Zacks Rank of 3 (Hold) [7] - The company is positioned well for income investors, especially compared to tech start-ups or growth businesses that typically do not offer dividends [6][7]

Group 1 - Oscar Health, Inc. (OSCR) experienced a decline of 4.62% to $20.45, underperforming the S&P 500's daily loss of 0.11% [1] - Over the past month, shares of Oscar Health have increased by 50.35%, while the Finance sector and S&P 500 gained 3.03% and 5.17% respectively [1] Group 2 - The upcoming earnings report for Oscar Health is expected to show an EPS of $0.34, reflecting a 70% increase year-over-year, with projected revenue of $2.86 billion, up 28.96% from the previous year [2] - Full-year estimates predict earnings of $0.61 per share and revenue of $11.21 billion, indicating year-over-year growth of 510% and 22.12% respectively [3] Group 3 - Recent modifications to analyst estimates for Oscar Health suggest a positive outlook, as these revisions often indicate short-term business trends [4] - The Zacks Rank system, which assesses estimate changes, currently ranks Oscar Health at 3 (Hold), with a consensus EPS projection that has decreased by 11.11% in the past 30 days [5][6] Group 4 - Oscar Health has a Forward P/E ratio of 34.96, significantly higher than the industry average of 10.13, indicating that the company is trading at a premium [7] - The Insurance - Multi line industry, part of the Finance sector, holds a Zacks Industry Rank of 95, placing it in the top 39% of over 250 industries [7][8]